Myoridge logo — Introducing new cell engineering options to the world throug...

Myoridge

Introducing new cell engineering options to the world through culture media

Founded 2016 Japan Japan 4 employees Series Unknown Total: $359.36M Care Economy, Health Care

General Information

Company Name Myoridge
Founded Year 2016
Location Japan Japan +1
Employees 4
Industries Care Economy, Health Care
Funding Stage Series Unknown
Social

Get notified when Myoridge moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Myoridge

Myoridge is a Japan-based startup in the Health Care industry, founded in 2016. The company specializes in culture media and cells, offering custom culture media for cell therapy and immunotherapy, as well as the development of culture media that amplify or control specific cell functions. Additionally, Myoridge develops and supplies culture media tailored to individual needs, such as growth ability, cost reduction, and storage. Moreover, the company is involved in the development of iPS cells for specific disease models and supports the development of differentiation induction technology for various cells. Their latest feat is the ¥142.36M Venture Round investment at 01 March 2021, with funding from Kyoto University Innovation Capital Co., Ltd and RFI Advisors. Myoridge's slogan "Introducing new cell engineering options to the world through culture media" encapsulates its commitment to advancing cell engineering options in the global arena.

Taxonomy: cell engineering, culture media, contract research, cell therapy, immunotherapy, custom culture media, cell function control, iPS cells, disease models, differentiation induction technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 2
Investor
•••• ••••
01 Mar 2021
Seed Round •••••• 2
Investor
•••• ••••
17 Jan 2020
Seed Round •••••• 1
Investor
03 Apr 2017

Myoridge Alternatives & Competitors

Myoridge vs

MediumBank, the culture Medium optimization and development expert by your side!

Series B
3 employees
Biotechnology
Myoridge vs

The one-stop shop for human and animal primary cells, customized media, and cell culture tools.

17 employees
Biotechnology, Health Care
Myoridge vs

Helping the Scientists of Today Discover the Science of Tomorrow

49 employees
Biotechnology, Clean Energy

FAQ About Myoridge

Introducing new cell engineering options to the world through culture media
Myoridge was founded in 2016.
Myoridge is headquartered in Japan.
Myoridge operates in the following industries: Care Economy, Health Care.
Myoridge has approximately 4 employees.
Myoridge has completed 3 funding rounds, raising a total of $359.36M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Myoridge include Shanghai MediumBank Biotechnology Co., LTD., PELOBiotech GmbH, ScienCell Research Laboratories, CellRev, Cell Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Myoridge and Shanghai MediumBank Biotechnology Co., LTD. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Myoridge and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes